Polycystic ovary syndrome (PCOS)

Exam relevance: in 15 of more than 150 board exam reports · rank 49

Synonyms
polycystic ovary syndrome, PCOS, polycystic ovaries
Specialty
Gynaecology · Endocrinology & cycle
Images
Ultrasound 1 · Clinical 3
Exam relevance
15 of more than 150 reports · rank 49
In the app
2 flashcards · GynFuchs
Last updated
11/2026 · Dr. Pascal Bafteh
Contents
  1. Images (4)
  2. Definition
  3. Occurrence & epidemiology
  4. Aetiopathogenesis
  5. Clinical features
  6. Diagnosis
  7. Treatment principles
  8. Keep learning in the app
  9. Further reading (selection)
  10. Cross-references

Images (4)

Polycystic ovary syndrome (PCOS) – Transvaginal sonography with three-dimensional post-processing: the numerous follicles of a polycystic ovary are outlined in colour and numberedUltrasound
Transvaginal sonography with three-dimensional post-processing: the numerous follicles of a polycystic ovary are outlined in colour and numberedImage: Di Michele S, Fulghesu AM, et al. (Wikimedia Commons) · CC BY-SA 4.0 · Source
Polycystic ovary syndrome (PCOS) – face – clinical photo: Hirsutism: coarse terminal hair growth on the chin and cheek
Hirsutism: coarse terminal hair growth on the chin and cheek (face)Image: Drhan9394 (Wikimedia Commons) · CC0 · Source
Polycystic ovary syndrome (PCOS) – clinical photo: Androgenetic alopecia in PCOS (HAIR-AN syndrome): receding frontal hairline and thinning hair on the crown of the scalp, plus inflammatory acne papules along the hairline
Androgenetic alopecia in PCOS (HAIR-AN syndrome): receding frontal hairline and thinning hair on the crown of the scalp, plus inflammatory acne papules along the hairlineImage: Gheshlagh RA, Topsakal S (Case Reports in Medicine 2025, doi:10.1155/carm/5825601) · CC BY 4.0 · Source
Polycystic ovary syndrome (PCOS) – clinical photo: Acanthosis nigricans in a skin fold in PCOS (HAIR-AN syndrome): velvety, thickened, brownish-dark skin with accentuated skin markings, a sign of insulin resistance
Acanthosis nigricans in a skin fold in PCOS (HAIR-AN syndrome): velvety, thickened, brownish-dark skin with accentuated skin markings, a sign of insulin resistanceImage: Gheshlagh RA, Topsakal S (Case Reports in Medicine 2025, doi:10.1155/carm/5825601) · CC BY 4.0 · Source
1 / 4

Definition

Rotterdam Criteria

  • First criterion: oligo- and/or anovulation.
  • Second criterion: clinical and/or biochemical hyperandrogenism.
  • Third criterion: polycystic ovaries (ultrasound).
  • What is additionally required: exclusion of other causes (diagnosis of exclusion).
  • In adolescents in the first few years after menarche: ultrasound criterion does not apply.

Occurrence & epidemiology

  • PCOS is the most common hormonal disorder in women of reproductive age: by the Rotterdam criteria about 10–13 % are affected worldwide.
  • PCOS is common in all ethnic groups, and prevalence is broadly similar across world regions, possibly somewhat higher in South East Asia and the Eastern Mediterranean; the presentation may differ between ethnic groups.
  • The syndrome accompanies those affected across the lifespan, from adolescence to after the menopause.

Aetiopathogenesis

  • The cause is complex and not fully understood. Obesity, physical inactivity, inflammation and epigenetic changes may aggravate the condition.
  • Many women with PCOS have insulin resistance with raised insulin levels, regardless of body weight and androgen levels. Insulin increases androgen production in the ovary.
  • When LH is high, the theca cells of the ovary produce more androgens. If FSH is relatively low at the same time, no dominant follicle may be selected: ovulation fails, and many small follicles arrest in their growth.

Clinical features

What Belongs to PCOS but Is Not in the Criteria

  • Pathogenetically central: insulin resistance with hyperinsulinaemia.
  • Further risks: dyslipidemia, hypertension, fatty liver.
  • Long-term gynaecological risk: endometrial hyperplasia to carcinoma.

Differentiating the Terms

  • Hirsutism: terminal hair at androgen-dependent sites.
  • Hypertrichosis: androgen-independent hair growth, often drug-induced.
  • Virilisation: hirsutism plus clitoromegaly, voice deepening.
  • How hirsutism is graded: using the Ferriman-Gallwey score (9 body regions).
  • What rapid progression with virilisation means: suspicion of androgen-producing tumor (urgent workup!).

Associated conditions and risks

  • Skin and hair: in adults, hirsutism is the strongest pointer to raised androgens. Acne and female-pattern hair loss on their own are only weak indicators.
  • Metabolism: regardless of age and body weight, the risk of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes is increased. Cardiovascular risk is also considered increased, although it is low overall before the menopause.
  • Mental health: depressive symptoms and anxiety disorders are considerably more common. Body image can be affected, and eating disorders occur regardless of weight.
  • Sleep: obstructive sleep apnoea is considerably more common, also independently of body weight.
  • Endometrium: before the menopause the risk of endometrial hyperplasia and endometrial cancer is markedly increased, but the absolute chance of endometrial cancer remains low.
  • Pregnancy: women with PCOS have a higher risk of complications during pregnancy.

Diagnosis

Ovary on Ultrasound

  • Follicle count criterion according to current definition: ≥ 20 follicles (2–9 mm) per ovary.
  • Alternative criterion: ovarian volume > 10 ml (without follicle/corpus luteum).
  • Typical distribution of follicles: string of pearls, subcapsular.
  • Important clarification: PCO alone is not a syndrome.

Laboratory Findings and Their Interpretation

  • Tests performed: testosterone, SHBG, FAI, DHEAS, LH, FSH, E2, PRL, TSH.
  • Classic but not mandatory constellation: elevated LH-FSH ratio.
  • Where ovarian androgens are produced: in the theca cells.
  • Where DHEAS originates: from the adrenal cortex.
  • What a markedly elevated testosterone necessitates: ruling out an androgen-producing tumour/CAH.
  • Why AMH is often high: many small follicles produce AMH.

Treatment principles

  • Treatment depends on the main symptoms and the wish for pregnancy; in women with excess weight, lifestyle change with weight reduction is the first step.
  • If pregnancy is not desired, cycle disorders and hyperandrogenism are treated with combined hormonal contraceptives, supplemented with antiandrogens if necessary.
  • If pregnancy is desired, ovulation induction, primarily with aromatase inhibitors, is the next step, followed by gonadotrophins or assisted reproduction if needed; metabolic risks such as diabetes are assessed regularly.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Polycystic ovary syndrome (PCOS) with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 2 flashcards on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Polyendocrine Metabolic Ovarian Syndrome (NCBI Bookshelf)
  2. International evidence-based PCOS guideline 2023 (Teede et al., Human Reproduction 2023)
  3. Review of the diagnosis and pathophysiology of PCOS (2023)
  4. DocCheck Flexikon, Polyzystisches Ovarialsyndrom
  5. DocCheck Flexikon, Hirsutismus

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Postmenopausal osteoporosis · Premature ovarian insufficiency (POI) · Premenstrual syndrome (PMS/PMDD)

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.